View clinical trials related to Malignant Melanoma of Skin.
Filter by:The goal of this clinical trial is to evaluate the safety and tolerability of intratumoral injections of PH-762 in squamous cell carcinoma, melanoma, or Merkel cell carcinomas of the skin, to understand what the body does to the PH-762, and to observe how the tumor responds to the drug. Participants will receive four injections of PH-762 at weekly intervals, into a single tumor, followed by surgical removal of the tumor approximately two weeks later.
Within the first year after diagnosis, data on employment and quality of life will be collected and evaluated in patients with malignant melanoma